COVID-19 vaccine for youth is coming

By fall, those age 12 to 17 can start rolling up their sleeves to get protection against the pandemic. Younger children will follow in the first of 2022.

By

National News

March 10, 2021 - 10:03 AM

A boy receives a free — but unpleasant — COVID-19 test in Los Angeles amid the coronavirus pandemic. Photo by (Mario Tama/Getty Images/TNS)

As adults in the United States continue to line up for their COVID-19 vaccines, children and teens have largely been kept out of the queue. That could soon change.

The nation’s top infectious diseases expert says that by fall, he expects to have data showing that children and teens age 12 to 17 can start rolling up their sleeves for COVID-19 shots. Younger children could follow in the first quarter of 2022.

“We project that high school students will very likely be able to be vaccinated by the fall term — maybe not the very first day, but certainly in the early part of the fall for that fall educational term,” Dr. Anthony Fauci said Sunday on CBS’s “Face the Nation.”

Children appear to have largely been spared the worst ravages of COVID-19, often suffering mild or minimal symptoms. And student vaccinations are not needed for safe school reopenings, experts say. Still, a wide-scale vaccination of America’s children and teens could offer some peace of mind to families — and would provide welcome aid in the effort to achieve herd immunity against the coronavirus.

“When you get the overwhelming majority of the population vaccinated, the level of virus in the community gets so low that the risk of infection is going to be minuscule,” Fauci said this week during a virtual event held by Tufts University.

Currently, no COVID-19 vaccine is authorized for use in children under the age of 16. But several vaccine makers are already testing their shots in younger teens and some pre-teens, and others have committed to doing so soon.

It’s all part of a push to get as many Americans protected against the virus as possible. And it can’t come fast enough for many doctors.

The American Academy of Pediatrics issued a call late last year for manufacturers to include children in their clinical trials because there’s no other way to judge whether the vaccines are safe and effective for them.

“If we do not add children to these research trials very soon, there will be a significant delay in when children are able to access potentially life-saving vaccines. This is unconscionable,”  academy President Dr. Sara H. Goza said in a statement late last year.

Johnson & Johnson COVID-19 vaccine Photo by (Michael Ciaglo/Getty Images/TNS)

It’s true that children appear to be far less impacted than adults, particularly the elderly. Despite accounting for 22% of the U.S. population, as of March 9,  children under 18 made up 11.6% of nearly 22 million cases, and less than 0.2% of nearly 383,000 COVID-19 deaths, according to the Centers for Disease Control and Prevention. (The U.S.  has more than 29 million cases and more than 527,000 deaths, according to current Johns Hopkins University data.)

But that still amounts to a lot of needless suffering and tragedy, said Dr. Robert Frenck, a pediatric infectious disease specialist at Cincinnati Children’s Hospital Medical Center. Data from the CDC show that 428,502 children ages 4 and under have been sickened with COVID-19 since the start of the pandemic, and 94 of them have died. Another 2,078,245 kids between the ages of 5 and 17 have had COVID-19, and 194 have died.

“These are … healthy kids that should have had a normal life ahead of them, and COVID changed that,” Frenck said.

Writing in the journal Clinical Infectious Diseases, several doctors made the case that vaccinating children was a critical move in the fight against the pandemic — not to mention crucial to protect youth against unnecessary suffering and risk of death.

“The direct COVID-19 impact upon children is greater than that observed for a number of other pathogens for which we now have effective pediatric vaccines,” they wrote. “Additionally, the role of children in SARS-CoV-2 transmission has clearly been underappreciated.”

The researchers pointed to several studies that suggest children may be effective transmitters of the virus. Among them: a number of studies comparing virus levels in the respiratory tract of children to that in adults; and a CDC study of a Georgia summer camp where 44% of the 597 attendees, trainees and staffers were infected.

Related